Navigating the complexities of the pharmaceutical industry, from innovator economics to generics, CRDMO, and biosimilars for ...

The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent ...

The drug and biotech sector is facing multiple headwinds. President Trump has warned of heavy tariffs, as high as 250%, on ...

The US biotechnology sector has been in a downturn since early 2022, with few signs of a rebound. The S&P Biotech ETF, or XBI ...

CES is a process to evaluate whether the effects ... to match that of the original drug completely, unlike generic drugs, which are chemical syntheses. If efficacy tests are strengthened in ...

Another way to reduce prices is to ease drug imports into the U.S. By one estimate, more than two-thirds of the top ...

Currently, companies that wish to conduct laboratory tests on new drug formulations must secure a formal licence from the Central Licensing Authority, a process that can take up to 90 days. The ...

Investigative journalists have been writing about problems with generic drugs for years. One example we recommend is Katherine Eban’s 2019 book “Bottle of Lies: The Inside Story of the Generic Drug ...

FDA approves Teva’s first generic GLP-1 drug for weight loss, based on Novo Nordisk’s Saxenda. Saxenda recorded $165 million in annual sales as of June 2025 ...

Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential ...

There’s still much more to come from the White House on tariffs, but the European Union has now reached a trade agreement with the U.S. The White House has settled on a 15% tariff rate for generic ...

Dissolution variability was noted in 6 generic extended-release capsules while 3 of the authorized generic extended-release capsules were more closely aligned with the dissolution profiles of the ...